CRIS Current Research Information System

MONTANARO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.231
AS - Asia 4.002
EU - Europa 3.368
AF - Africa 211
SA - Sud America 193
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.188
SG - Singapore 1.093
VN - Vietnam 1.072
CN - Cina 1.002
IT - Italia 850
GB - Regno Unito 764
DE - Germania 423
SE - Svezia 295
HK - Hong Kong 267
UA - Ucraina 261
FR - Francia 208
IN - India 177
RU - Federazione Russa 170
BR - Brasile 139
IE - Irlanda 106
JP - Giappone 105
KR - Corea 94
NL - Olanda 65
CI - Costa d'Avorio 64
ZA - Sudafrica 62
FI - Finlandia 48
EE - Estonia 37
BE - Belgio 33
JO - Giordania 31
TG - Togo 31
PH - Filippine 28
AR - Argentina 25
CA - Canada 24
GR - Grecia 20
AT - Austria 18
SC - Seychelles 18
BD - Bangladesh 16
TR - Turchia 16
ID - Indonesia 15
NG - Nigeria 15
IR - Iran 14
CH - Svizzera 13
MX - Messico 12
PK - Pakistan 12
IQ - Iraq 11
AU - Australia 10
PL - Polonia 10
TH - Thailandia 10
TW - Taiwan 10
HR - Croazia 9
CO - Colombia 8
BG - Bulgaria 7
EC - Ecuador 7
LT - Lituania 6
UZ - Uzbekistan 6
AL - Albania 5
CL - Cile 5
ES - Italia 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
EG - Egitto 4
KE - Kenya 4
TN - Tunisia 4
CZ - Repubblica Ceca 3
LB - Libano 3
MA - Marocco 3
VE - Venezuela 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
KZ - Kazakistan 2
NP - Nepal 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BT - Bhutan 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NO - Norvegia 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.016
Salva come PNG Salva come JPEG
Città #
Singapore 737
Southend 656
Santa Clara 353
Ashburn 345
Chandler 339
Fairfield 292
Hong Kong 259
San Jose 252
Dong Ket 239
Hefei 207
Ho Chi Minh City 207
Jacksonville 199
Princeton 183
Wilmington 170
Hanoi 156
Woodbridge 137
Ann Arbor 135
Houston 132
Seattle 131
Dublin 106
Beijing 101
Tokyo 95
Dallas 94
Cambridge 91
Boardman 87
Lauterbourg 86
Seoul 84
Los Angeles 81
Padova 69
Westminster 68
Abidjan 64
Nanjing 62
Bologna 58
Rome 46
Mülheim 45
Milan 43
Helsinki 42
Berlin 39
Bremen 39
Buffalo 37
Council Bluffs 36
Medford 36
Saint Petersburg 35
Shenyang 34
Amman 31
Lomé 31
Haiphong 30
Brussels 29
Da Nang 28
New York 26
San Diego 26
San Venanzo 26
Hebei 25
Nanchang 23
Jinan 22
Munich 22
Shanghai 22
Frankfurt am Main 21
Florence 20
Changsha 19
Guangzhou 19
Jiaxing 19
Redondo Beach 19
The Dalles 19
Mahé 17
Zhengzhou 15
Bengaluru 14
Dearborn 14
Olalla 14
Palermo 14
Abeokuta 13
London 13
Shenzhen 13
Tianjin 13
Wuhan 13
Biên Hòa 12
Phoenix 12
São Paulo 11
Verona 11
Fuzhou 10
Ningbo 10
Norwalk 10
Nuremberg 10
Orem 10
Atlanta 9
Bến Tre 9
Chennai 9
Falkenstein 9
Falls Church 9
Hangzhou 9
Kunming 9
Xi'an 9
Bühl 8
Ferrero 8
Haikou 8
Lanzhou 8
Modena 8
Pescara 8
Rio de Janeiro 8
Suzhou 8
Totale 7.569
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 565
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions 281
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 270
Le basi della farmacologia 248
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 223
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 211
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 211
Ticlopidine Safety Profile: A Case/Non-Case Study on the Basis of the Spontaneous ADRs Reporting in Italy 207
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 205
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 191
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 191
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 189
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 185
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 182
An update on the first decade of the European centralized procedure: how many innovative drugs? 181
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 181
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database 177
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 172
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug’s safety profile. 168
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database 164
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data 161
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database 155
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations 154
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 152
Hepatic adverse drug reactions: a case/non-case study in Italy 152
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 152
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 151
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 151
Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 151
Antibiotic use in Italian hospitals 2002-2004. 150
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations 150
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database 148
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy 147
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 147
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 145
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 143
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine 142
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 142
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 139
Un commento alla lettera sulla definizione di farmaco innovativo 139
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 139
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 139
Initial treatment of hypertension and adherence to therapy in general practice in Italy 138
Therapeutic innovation of the drugs approved by the EMEA-centralised procedure 137
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 136
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 135
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 134
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 133
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 132
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. 129
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System 127
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 127
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 122
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 122
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System 122
Natalizumab: a country-based surveillance program 121
Farmaci EMEA ed innovazione terapeutica 120
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice 120
The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate. 119
Progetto europeo di confronto dell'uso dei farmaci 119
Three years of experience: the Italian registry and safety data update 119
La rimborsabilità di memantina - il trilemma di Münchausen 118
Pattern of Triptan Use in a Sample of the Italian General Population 118
Prevenire gli errori in terapia. Strategie per i farmacisti 116
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 112
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 108
Removal of the EMA orphan designation upon request of the sponsor: cui prodest? 108
The Italian Surveillance Program on Natalizumab 107
Monitoring the use of disease-modifying drugs in multiple sclerosis 107
Hepatic adverse drug reactions: analysis of an italian spontaneous reporting database. 101
Prescrizione di Entacapone nella Regione Emilia-Romagna 96
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 96
The Italian Natalizumab Registry: a 1-year follow-up 95
La medicina basata sulle prove - Istruzioni per l'uso. Prima edizione italiana 95
Pattern of use of NSAIDs in the Italian general population: a questionnaire-based study 92
La medicina basata sulle prove. Dalle fonti di conoscenza alla realtà del singolo paziente. Seconda edizione 92
Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database 85
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data 79
On criteria to evaluate the therapeutic innovation of drugs 78
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data 73
Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis 72
Overview of Orphan Medicines in European Union: An Analysis of Regulatory and Technical-Scientific Aspects 55
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab 54
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview 40
Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use 31
Use of anti-asthmatic drugs in Italy: Analysis of prescriptions in general practice in the light of guidelines for asthma treatment 30
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: An analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions 17
Totale 12.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.228
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 0 0 0 0 0 34 67 343
2021/20221.412 184 49 62 98 120 66 25 93 51 91 355 218
2022/20231.483 159 183 100 203 99 128 28 86 261 45 127 64
2023/2024498 46 69 37 60 42 43 32 42 22 39 50 16
2024/20251.731 69 230 143 86 440 132 87 52 30 55 81 326
2025/20263.756 240 370 408 340 502 202 548 176 717 253 0 0
Totale 12.238